硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
抗人 cIAP2 抗体对
试剂盒

抗人 cIAP2 抗体对

01AB01032

Baculoviral IAP repeat containing 3 (BIRC3), also known as cIAP2, is a multifunctional protein that belongs to the inhibitor of apoptosis (IAP) family and plays a crucial role in regulating apoptosis, inflammation, and immune signaling. Structurally, BIRC3 contains three baculoviral IAP repeat (BIR) domains, a ubiquitin-associated (UBA) domain, a caspase recruitment domain (CARD), and a RING finger domain, which collectively enable it to inhibit caspases and modulate various signaling pathways, including those involved in mitogenic kinase activity and inflammatory responses. BIRC3 interacts with tumor necrosis factor receptor-associated factors (TRAF1 and TRAF2), thereby inhibiting apoptosis and influencing cell survival, particularly under conditions such as serum deprivation. The protein is widely expressed across tissues, including immune and endocrine organs, and its function can be further diversified by alternative 3' untranslated regions (3' UTRs) that facilitate the assembly of specific protein complexes, impacting processes like B cell migration. Dysregulation or mutation of BIRC3 has been implicated in various diseases, notably certain leukemias and lymphomas, where altered BIRC3 function can contribute to abnormal cell survival and resistance to apoptosis.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
BIRC3
基因别名
API2; MIHC; RNF49
蛋白别名
baculoviral IAP repeat containing 3; cIAP2
UniProt
Q13489
物种
Human

产品详情

靶点名称
cIAP2
蛋白名称
baculoviral IAP repeat containing 3
蛋白别名
Baculoviral IAP repeat-containing protein 3; Apoptosis inhibitor 2; API2; Cellular inhibitor of apoptosis 2; C-IAP2; IAP homolog C; Inhibitor of apoptosis protein 1; hIAP-1; hIAP1; RING finger protein 49; RING-type E3 ubiquitin transferase BIRC3; TNFR2-TRAF-signaling complex protein 1
靶点基因名
BIRC3
基因别名
API2; MIHC; RNF49
UniProt
Q13489
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Baculoviral IAP repeat containing 3 (BIRC3), also known as cIAP2, is a multifunctional protein that belongs to the inhibitor of apoptosis (IAP) family and plays a crucial role in regulating apoptosis, inflammation, and immune signaling. Structurally, BIRC3 contains three baculoviral IAP repeat (BIR) domains, a ubiquitin-associated (UBA) domain, a caspase recruitment domain (CARD), and a RING finger domain, which collectively enable it to inhibit caspases and modulate various signaling pathways, including those involved in mitogenic kinase activity and inflammatory responses. BIRC3 interacts with tumor necrosis factor receptor-associated factors (TRAF1 and TRAF2), thereby inhibiting apoptosis and influencing cell survival, particularly under conditions such as serum deprivation. The protein is widely expressed across tissues, including immune and endocrine organs, and its function can be further diversified by alternative 3' untranslated regions (3' UTRs) that facilitate the assembly of specific protein complexes, impacting processes like B cell migration. Dysregulation or mutation of BIRC3 has been implicated in various diseases, notably certain leukemias and lymphomas, where altered BIRC3 function can contribute to abnormal cell survival and resistance to apoptosis.